Sanofi, an R&D-driven, AI-powered biopharma company, aimed to automate and streamline the case management process of its pharmacovigilance journey.
The Challenge
Pharmacovigilance is built on managing “adverse events”, which are unwanted medical issues. This means gathering reports about the effects from multiple sources, including phone calls, letters, emails, and online.
The Solution: IQVIA Vigilance Platform
Sanofi sped up their automation journey through
“We decided to move forward with IQVIA for three main reasons. First, the tool as it was presented to us, as well as the roadmap for the future, were aligned with our vision. Second, we have a long-term relationship with IQVIA. And third, we acknowledge the team’s deep expertise and experience.”
– Julie Girod, AVP, Global Head of Case Management and Medical Evaluation, Sanofi
The Results
This collaborative partnership with IQVIA represents a fundamental shift in how pharmacovigilance is conducted, leading to a significant improvement in medical evaluations.
The technology is enhanced by real-world feedback and use cases, influencing industry best practices. This has already yielded a 15% cost reduction, with a goal of 50% by 2027. Crucially, medical teams are now able to prioritize complex, high-value safety issues.
Sanofi plans to adopt the IQVIA Vigilance Platform from beginning to end, making it one of the few pharma companies using a fully, automated system. By leveraging AI and automation, teams can now focus their energy where it can make a real difference.
Seamlessly connect to IQVIA OneKey
Categories
Agentforce Content
IQVIA drives digital transformation with precise insights and robust CRM strategies. Leveraging partnerships and Salesforce investments, we offer tailored, flexible solutions based on extensive life sciences expertise, ensuring successful client outcomes.
